Israel Englander’s Filana Therapeutics FLNA Stock Holding History

Israel Englander’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$621K	–	7314
2021 Q3	$621K	Buy	10,000 +3,000	+43%	+$250K	﹤0.01%	5151
2021 Q2	$598K	Buy	+7,000	New	+$375K	﹤0.01%	5143

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Israel Englander's FLNA Position: Q2 2026 in Review

Israel Englander sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 72,588 shares — an estimated $123K sold.

Israel Englander first reported a position in FLNA in Q2 2013 and held it in 23 quarters. The position peaked at $10.3M in Q1 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Israel Englander reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 72,588 Filana Therapeutics shares in Q2 2026, an estimated $123K.
Israel Englander first reported a position in Filana Therapeutics in Q2 2013 and held it in 23 quarters.
Israel Englander's Filana Therapeutics position peaked at $10.3M in Q1 2021.
85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.